Merck agrees to acquire ArQule in $2.7bn deal
ArQule develops investigational candidate ARQ 531, an oral Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of B-cell…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Dec 19
ArQule develops investigational candidate ARQ 531, an oral Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of B-cell…
09 Dec 19
Janssen has also signed a supply agreement with XBiotech to produce clinical supplies of bermekimab, using its advanced…
06 Dec 19
Thermo Fisher’s new facility will support the development, testing and manufacture of viral vectors, which are crucial in…
04 Dec 19
The acquisition is expected to be completed in the first quarter of 2020, subject to customary closing conditions,…
03 Dec 19
Covering an area of 65,000ft², Lilly Gateway Labs will provide 32 advanced private lab modules — with lab…
Boris Johnson and Jeremy Corbyn have repeatedly clashed over healthcare in the UK, and Labour claims the Prime…
Visionable CEO Alan Lowe says paramedics using video calls to contact consultants and digital appointments with GPs could…
Continued funding from British companies is needed to give people confidence and peace of mind in the NHS,…
25 Nov 19
The acquisition will enable Novartis to use the core commercial capabilities, including global cardiovascular field force of The…
25 Nov 19
The new manufacturing facility includes drug substance manufacturing, drug product manufacturing along with quality control labs